Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation

International Journal of Biochemistry and Cell Biology

Volumn 43, Issue 6, 2011, Pages 936-945

  Dietz, Kevin N ^a   Miller, Patrick J ^a   Iyengar, Aditi S ^a   Loupe, Jacob M ^a   Hollenbach, Andrew D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar rhabdomyosarcoma; Myogenesis; Pax3; Pax3 FOXO1; Phosphorylation

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIBODIES, PHOSPHO-SPECIFIC; CASEIN KINASE II; CELL LINE, TUMOR; CHILD; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MUSCLE NEOPLASMS; MYOBLASTS; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; PHOSPHORYLATION; RHABDOMYOSARCOMA, ALVEOLAR; SERINE;

EID: 79955893149     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2011.03.010     Document Type: Article

References (28)

1. R. Amstutz, M. Wachtel, H. Troxler, P. Kleinert, M. Ebauer, and T. Haneke Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities Cancer Res 68 2008 3767 3776
2. J. Bain, L. Plater, M. Elliott, N. Shpiro, C.J. Hastie, and H. McLauchlan The selectivity of protein kinase inhibitors: a further update Biochem J 408 2007 297 315
3. R. Bhat, Y. Xue, S. Berg, S. Hellberg, M. Ormo, and Y. Nilsson Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 J Biol Chem 278 2003 45937 45945 (Pubitemid 37432740)
4. S.C. Boutet, M.H. Disatnik, L.S. Chan, K. Iori, and T.A. Rando Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors Cell 130 2007 349 362 (Pubitemid 47081135)
5. W.J. Boyle, P. van der Geer, and T. Hunter Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates Methods Enzymol 201 1991 110 149
6. A.S. Brack, I.M. Conboy, M.J. Conboy, J. Shen, and T.A. Rando A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis Cell Stem Cell 2 2008 50 59
7. M. Buckingham, and F. Relaix The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions Annu Rev Cell Dev Biol 23 2007 645 673
8. R.J. Davis, and F.G. Barr Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma Proc Natl Acad Sci U S A 94 1997 8047 8051 (Pubitemid 27343774)
9. K.N. Dietz, P.J. Miller, and A.D. Hollenbach Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation Biochemistry 48 2009 11786 11795
10. B.W. Doble, and J.R. Woodgett GSK-3: tricks of the trade for a multi-tasking kinase J Cell Sci 116 2003 1175 1186 (Pubitemid 36410657)
11. J.A. Epstein, P. Lam, L. Jepeal, R.L. Maas, and D.N. Shapiro Pax3 inhibits myogenic differentiation of cultured myoblast cells J Biol Chem 270 1995 11719 11722
12. J.A. Epstein, B. Song, M. Lakkis, and C. Wang Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor Mol Cell Biol 18 1998 4118 4130 (Pubitemid 28287935)
13. S. Frame, and P. Cohen GSK3 takes centre stage more than 20 years after its discovery Biochem J 359 2001 1 16 (Pubitemid 32939202)
14. W.J. Fredericks, N. Galili, S. Mukhopadhyay, G. Rovera, J. Bennicelli, and F.G. Barr The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 Mol Cell Biol 15 1995 1522 1535
15. N. Galili, R.J. Davis, W.J. Fredericks, S. Mukhopadhyay, F.J. Rauscher 3rd, and B.S. Emanuel Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma Nat Genet 5 1993 230 235 (Pubitemid 23330384)
16. B.J. Hazelton, J.A. Houghton, D.M. Parham, E.C. Douglass, P.M. Torrance, and H. Holt Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma Cancer Res 47 1987 4501 4507 (Pubitemid 17128155)
17. A.D. Hollenbach, J.E. Sublett, C.J. McPherson, and G. Grosveld The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx EMBO J 18 1999 3702 3711 (Pubitemid 29308849)
18. T. Hunter, and M. Karin The regulation of transcription by phosphorylation Cell 70 1992 375 387
19. J. Khan, R. Simon, M. Bittner, Y. Chen, S.B. Leighton, and T. Pohida Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays Cancer Res 58 1998 5009 5013 (Pubitemid 28521149)
20. P.Y. Lam, J.E. Sublett, A.D. Hollenbach, and M.F. Roussel The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain Mol Cell Biol 19 1999 594 601 (Pubitemid 29018461)
21. P.J. Miller, K.N. Dietz, and A.D. Hollenbach Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts Protein Sci 17 2008 1979 1986
22. P.J. Miller, and A.D. Hollenbach The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis Biochim Biophys Acta 1770 2007 1450 1458 (Pubitemid 47384992)
23. I. Petak, L. Douglas, D.M. Tillman, R. Vernes, and J.A. Houghton Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis Clin Cancer Res 6 2000 4119 4127
24. T.A. Rando, and H.M. Blau Methods for myoblast transplantation Methods Cell Biol 52 1997 261 272 (Pubitemid 128787397)
25. D.N. Shapiro, J.E. Sublett, B. Li, J.R. Downing, and C.W. Naeve Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma Cancer Res 53 1993 5108 5112 (Pubitemid 23333374)
26. J.L. van der Velden, A.M. Schols, J. Willems, M.C. Kelders, and R.C. Langen Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3 J Biol Chem 283 2008 358 366
27. B.A. Williams, and C.P. Ordahl Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification Development 120 1994 785 796 (Pubitemid 24111544)
28. F.Y. Zeng, H. Dong, J. Cui, L. Liu, and T. Chen Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells Biochem Biophys Res Commun 391 2010 1049 1055